Acta Pharm. 65 (2015) 215-233
Original research paper
Synthesis of
pyranopyrazolo N-glycoside
and pyrazolopyranopyrimidine C-glycoside derivatives as promising antitumor and antimicrobial
agents
HEND N. HAFEZ and ABDEL-RHMAN B. A. EL-GAZZAR
profelgazzar@yahoo.com;
abgazzar@imamu.edu.sa
1 Al-Imam
Mohammad Ibn Saud Islamic University (IMSIU), Faculty
of Science, Department of Chemistry, P.O. Box 90950, Riyadh 11623, Kingdom of
Saudi Arabia
2 Photochemistry
Department (Heterocyclic and Nucleosides Unit), National
Research Centre, Cairo, Egypt
Accepted February 17, 2015
As a part of systematic investigation of the synthesis and biological activities of pyrazole analogues linked to various heterocyclic systems, a new series of pyrazolo-N- nucleoside derivatives, pyrazolopyranopyrimidine and C-glycoside of pyrazolopyranotriazolo-pyrimidine derivatives was synthesized through the reaction of the key intermediate 6-amino-3-methyl-4-(substituted-phenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile (3a, b) with different reagents. Structures of the newly synthesized compounds were elucidated by elemental microanalysis and spectroscopic methods. The compounds were subjected to in vitro antitumor evaluation using the MTT assay. N-(β-D-ribofuranosyl)- and N-(β-D-xylofuranosyl)-6{[(1E)-4-chlorophenyl)-methylene]amino}4-(4-florophenyl)-3-methyl-1,4-dihydropyrano[2,3-c]-pyrazole-5-carbonitrile (6a, b) were the most active compounds against three human cancer cell lines. Also, most of the newly synthesized compounds exhibited high activity towards Gram-negative and Gram-positive bacteria. Compound 6a exhibited excellent activity towards bacteria compared to ofloxacine as the reference drug.
Keywords: N-nucleoside of pyranopyrazole, C-glycoside of pyrazolopyranotriazolopyrimidine,
anticancer activity, antimicrobial activity